Among older adults with atrial fibrillation, persistence with warfarin therapy is generally lower than what has been reported in clinical trials, according to an online study in Archives of Internal Medicine.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.